DK1053012T3 - Farmaceutiske sammensætninger omfattende PEG-asparaginase til behandling af HIV-infektioner - Google Patents

Farmaceutiske sammensætninger omfattende PEG-asparaginase til behandling af HIV-infektioner

Info

Publication number
DK1053012T3
DK1053012T3 DK99906749T DK99906749T DK1053012T3 DK 1053012 T3 DK1053012 T3 DK 1053012T3 DK 99906749 T DK99906749 T DK 99906749T DK 99906749 T DK99906749 T DK 99906749T DK 1053012 T3 DK1053012 T3 DK 1053012T3
Authority
DK
Denmark
Prior art keywords
treatment
pharmaceutical compositions
hiv infections
inhibitor compounds
peg
Prior art date
Application number
DK99906749T
Other languages
Danish (da)
English (en)
Inventor
Vassilios I Avramis
Lewis Cohen
Original Assignee
Enzon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enzon Pharmaceuticals Inc filed Critical Enzon Pharmaceuticals Inc
Application granted granted Critical
Publication of DK1053012T3 publication Critical patent/DK1053012T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/50—Hydrolases (3) acting on carbon-nitrogen bonds, other than peptide bonds (3.5), e.g. asparaginase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK99906749T 1998-02-09 1999-02-09 Farmaceutiske sammensætninger omfattende PEG-asparaginase til behandling af HIV-infektioner DK1053012T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7406698P 1998-02-09 1998-02-09
PCT/US1999/002480 WO1999039732A1 (en) 1998-02-09 1999-02-09 Pharmaceutical compositions comprising peg-asparaginase for the treatment of hiv infections

Publications (1)

Publication Number Publication Date
DK1053012T3 true DK1053012T3 (da) 2003-11-17

Family

ID=22117505

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99906749T DK1053012T3 (da) 1998-02-09 1999-02-09 Farmaceutiske sammensætninger omfattende PEG-asparaginase til behandling af HIV-infektioner

Country Status (10)

Country Link
EP (1) EP1053012B1 (ja)
JP (1) JP2002502826A (ja)
AT (1) ATE245444T1 (ja)
AU (1) AU752434B2 (ja)
CA (1) CA2319356A1 (ja)
DE (1) DE69909747T2 (ja)
DK (1) DK1053012T3 (ja)
ES (1) ES2203072T3 (ja)
WO (1) WO1999039732A1 (ja)
ZA (1) ZA991029B (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2368230A1 (en) * 1999-04-02 2000-10-12 Children's Hospital Los Angeles Use of asparaginase and glutaminase to treat autoimmune disease and graft versus host disease
JP2003506409A (ja) * 1999-08-06 2003-02-18 アヴェンティス ファーマシューティカルズ インコーポレイテッド Ｈｉｖ感染の治療用組成物及び方法
CA2404737C (en) 2000-04-03 2010-06-29 Santen Pharmaceutical Co., Ltd. Drug delivering substance containing polyalkylene glycol and phospholipid covalently bonded to drug
US6911460B2 (en) 2001-04-20 2005-06-28 Vion Pharmaceuticals, Inc. Antiviral agents and methods of treating viral infections
CN100536836C (zh) * 2002-11-26 2009-09-09 芝加哥大学 预防和治疗微生物介导的上皮紊乱的物质和方法
CA2574719A1 (en) * 2004-09-13 2006-03-23 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Health Canada Inhibition of feline calicivirus replication by asparaginase
CN100475270C (zh) 2006-01-20 2009-04-08 清华大学 一种治疗肿瘤的药物及其应用
CN101002945B (zh) 2006-01-20 2012-09-05 清华大学 一种用于肿瘤治疗的新型复合物
GB0608876D0 (en) * 2006-05-05 2006-06-14 Medivir Ab Combination therapy
CN101219219B (zh) 2007-01-10 2013-02-13 北京普罗吉生物科技发展有限公司 包含血管抑素或其片段的复合物、其制备方法及应用
WO2015033344A1 (en) * 2013-09-05 2015-03-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Methods and kits for inhibiting pathogenicity of group a streptococcus (gas) or group g streptococcus (ggs)
MA51224A (fr) * 2017-11-29 2020-10-07 Taiho Pharmaceutical Co Ltd Composés de sulfonamide et leur utilisation
US20210299233A1 (en) 2018-07-12 2021-09-30 The Children's Medical Center Corporation Method for treating cancer
CN115671102A (zh) * 2022-11-17 2023-02-03 中国科学院大学 3-ap在制备抑制痘病毒的药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2600256B1 (fr) * 1986-06-19 1988-09-16 Inst Nat Sante Rech Med Medicament et composition medicamenteuse pour le traitement des tumeurs ainsi que pour le traitement des maladies infectieuses dues aux virus
AU752370B2 (en) * 1997-06-09 2002-09-19 Children's Hospital Of Los Angeles Utilization of wolinella succinogenes asparaginase to treat diseases associated with asparagine dependence

Also Published As

Publication number Publication date
CA2319356A1 (en) 1999-08-12
EP1053012B1 (en) 2003-07-23
ES2203072T3 (es) 2004-04-01
DE69909747T2 (de) 2004-04-15
DE69909747D1 (de) 2003-08-28
JP2002502826A (ja) 2002-01-29
EP1053012A1 (en) 2000-11-22
ATE245444T1 (de) 2003-08-15
ZA991029B (en) 1999-09-30
AU2658499A (en) 1999-08-23
WO1999039732A1 (en) 1999-08-12
AU752434B2 (en) 2002-09-19

Similar Documents

Publication Publication Date Title
ATE377011T1 (de) Gamma-hydroxy-2-(fluoralkylaminocarbonyl)-1- piperazinpentanamide als hiv-proteasehemmer
DK1053012T3 (da) Farmaceutiske sammensætninger omfattende PEG-asparaginase til behandling af HIV-infektioner
BR0013771A (pt) Composto, métodos de tratamento de uma infecção viral em um mamìfero, de inibir a transcriptase reversa do hiv, e de prevenção da infecção do hiv ou de tratar a infecção do hiv, uso de um composto, e, composição farmacêutica
ATE252081T1 (de) Neue hiv-protease-inhibitoren
EA200200778A1 (ru) СПОСОБ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ИНФЕКЦИИ ГЕПАТИТА С В ОРГАНИЗМЕ ХОЗЯИНА, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ПРОТИВ ФЛАВИВИРУСА, СОЕДИНЕНИЕ ФОРМУЛЫ Ib - АКТИВНЫЙ АГЕНТ ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ИНФЕКЦИИ ГЕПАТИТА С ИЛИ ФЛАВИВИРУСА (ВАРИАНТЫ)
EA200701869A1 (ru) Пептидомиметические ингибиторы протеазы
GEP20104960B (en) USE OF [D-MeALa]3-[EtVal]4-CYCLOSPORIN FOR THE TREATMENT OF HEPATITIS C INFECTION AND PHARMACEUTICAL COMPOSITION COMPRISING SAID [D-MeAla]3-[EtVal]4-CYCLOSPORIN
SG52628A1 (en) Substituted cyclic carbonyls and derivatives thereof useful as retrobiral protease inhibitors
WO2006044968A3 (en) Combination therapy for treating viral infections
ATE327246T1 (de) Hepatitis c tripeptid inhibitoren
EA200400585A1 (ru) N-замещённые гидроксипиримидинон-карбоксамидные ингибиторы вич интегразы
ATE238998T1 (de) Substituierte benzimidazole als nicht-nucleoside reverse transcriptase inhibitore
BR9607625A (pt) Inibidores de protease retroviral sulfonamida hidroxietilamino de aminoácido heterociclocarbonila
DE69430385D1 (de) Hiv-proteaseinhibitoren
WO2001010454A3 (en) Pharmaceutical composition comprising peg-asparaginase for the treatment of hiv infection
EE9700165A (et) Ühendite kombinatsioon, meetod ja farmatseutiline kompositsioon HIV proteaasi ja HIV pöördtranskriptaasi inhibeerimiseks ning HIV infektsiooni vältimiseks või raviks, või AIDS-i või ARC raviks
HK1045456A1 (en) Novel therapeutic use of viral inflammation modulatory protein in blocking xenograft rejection
NO965591L (no) Kombinasjonsbehandling av HIV-infeksjon
UA41338C2 (uk) Спосіб інгібування ретровірусної інфекції, яка викликана вірусом імунодефіциту людини (віл), спосіб інгібування вірусу імунодефіциту людини (віл)
EA200000513A1 (ru) Комбинированная терапия для лечения спид
NO20024522D0 (no) Sammensetninger med anti-hiv-aktivitet
ATE232727T1 (de) Kombinationen von hiv-protease inhibitoren
UA31078A (uk) Інгібітор вірусу імунодефіциту людини ( даримід )
TR199902508T2 (xx) HIV proteaz inhibit�rleri.